Subject Area
General Surgery
Article Type
Original Study
Abstract
Background: A chronic anal fissure (CAF) is an ulcer that develops in the distal anal canal. This condition may be acute or chronic. An acute anal fissure is typically treated conservatively with dietary modifications and typically resolves within one to two weeks. The study aimed to compare efficacy, safety, and botulinum toxin A (BT) injection outcome in the CAF treatment vs lateral internal sphincterotomy (LIS).
Methods: This randomized controlled trial included 106 patients age >18 and both sexes had CAF who were admitted at General Surgery Department at Mansoura University Hospitals. Patients who entered the trial were randomized into 2 equal groups: Group 1; Patient underwent LIS and group 2; Patient underwent BT injection. A comprehensive history, general examination, and special investigations, such as an electrocardiogram (ECG), were conducted on all patients.
Results: Regarding the outcome, the complete healing was significantly increased in the group 1 (LIS group) than the group 2 (BT injection group) (88.68% vs. 67.92%, P=0.009), and the recurrence was significantly lower in group 1 (LIS group) than group 2 (BT injection group) (3.77% vs. 18.87%, P=0.028). The time of recurrence was insignificantly different between both groups, despite being delayed in the group 1 (LIS group).
Conclusions: While BT injection offers a safe, minimally invasive profile with faster early recovery, LIS remains significantly superior in terms of long-term healing and lower recurrence rates.
Recommended Citation
Tawfik, Shukri Salama; Abdel Latif, Atef Mohamed; Mohamed, Mohamed Khidr; and Mohamed, Tamer Youssef
(2026)
"Cutting The Knot or Relaxing the Muscle: A Comparative Study Between Botulinum Toxin Injection Versus Lateral Internal Sphincterotomy in Treatment of Chronic Anal Fissure,"
Mansoura Medical Journal: Vol. 56
:
Iss.
3
, Article 9.
Available at:
https://doi.org/10.58775/2735-3990.1632
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.


